We are live on ! Find out more
NM

Newtyn Management Portfolio holdings

AUM $936M
1-Year Est. Return 27.23%
This Fund
S&P 500
This Quarter Est. Return
+3.04%
1 Year Est. Return
+27.23%
3 Year Est. Return
+51.99%
5 Year Est. Return
+55.23%
10 Year Est. Return
+165.15%
AUM
$502M
AUM Growth
-$7.38M
Cap. Flow
-$23.3M
Cap. Flow %
-4.65%
Top 10 Hldgs %
68.95%
Holding
52
New
4
Increased
14
Reduced
13
Closed
12

Sector Composition

Rank Sector Weight
1 Healthcare 22.31%
2 Communication Services 20%
3 Technology 16.98%
4 Real Estate 10.11%
5 Consumer Discretionary 9.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ETNB
26
DELISTED
89bio
ETNB
$2.91M 0.58%
250,000
-22,500
-8% -$249K
MURA
27
DELISTED
Mural Oncology
MURA
$2.44M 0.49%
500,000
+55,000
+12% +$267K
BOLT icon
28
Bolt Biotherapeutics
BOLT
$7.47M
$2.38M 0.47%
85,000
+7,323
+9% +$170K
ADPT icon
29
Adaptive Biotechnologies
ADPT
$3.87B
$2M 0.4%
623,690
+301,690
+94% +$1.17M
PHAT icon
30
Phathom Pharmaceuticals
PHAT
$720M
$1.75M 0.35%
165,000
-481,760
-74% -$4.09M
OLMA icon
31
Olema Pharmaceuticals
OLMA
$1.03B
$1.7M 0.34%
150,000
AVIR icon
32
Atea Pharmaceuticals
AVIR
$379M
$1.62M 0.32%
400,000
-108,474
-21% -$425K
TECX
33
Tectonic Therapeutic
TECX
$538M
$1.43M 0.29%
93,241
-134,607
-59% -$2.13M
VNDA icon
34
Vanda Pharmaceuticals
VNDA
$312M
$1.28M 0.25%
311,000
+21,000
+7% +$84.1K
ALGS icon
35
Aligos Therapeutics
ALGS
$26.7M
$1.18M 0.23%
48,000
-2,200
-4% -$43.8K
FTH
36
Faeth Therapeutics
FTH
$743M
$977K 0.19%
46,512
-32,089
-41% -$553K
ADVM
37
DELISTED
Adverum Biotechnologies
ADVM
$653K 0.13%
46,189
-36,121
-44% -$549K
BDTX icon
38
Black Diamond Therapeutics
BDTX
$98.6M
$634K 0.13%
125,000
-155,000
-55% -$625K
LFLYW
39
DELISTED
Leafly Holdings, Inc. Warrant
LFLYW
$19K ﹤0.01%
634,640
AMBP icon
40
Ardagh Metal Packaging
AMBP
$2.9B
-2,464,881
Closed -$9.47M
GIII icon
41
G-III Apparel Group
GIII
$1.55B
-760,207
Closed -$25.8M
GTX icon
42
Garrett Motion
GTX
$5.78B
-1,029,523
Closed -$9.96M
NBBK icon
43
NB Bancorp
NBBK
$996M
-46,945
Closed -$631K
DFNS
44
T3 Defense Inc
DFNS
$85.9M
-27
Closed -$76.9K
TLYS icon
45
Tilly's
TLYS
$113M
-62,784
Closed -$473K
QTTB icon
46
Q32 Bio
QTTB
$462M
-77,737
Closed -$851K
ORKA
47
Oruka Therapeutics
ORKA
$5.9B
-22,443
Closed -$458K
CYT
48
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
-3,021,500
Closed -$9.19M
ARIZR
49
DELISTED
Arisz Acquisition Corp. Right
ARIZR
-250,000
Closed -$52.5K
MDRX
50
DELISTED
Veradigm Inc. Common Stock
MDRX
-1,461,692
Closed -$15.3M

Similar funds

Newtyn Management's Q1 2024 Portfolio in Review

As of Q1 2024, Newtyn Management held 52 positions worth $502M, down 1.4% from $509M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Newtyn Management withdrew a net $23.3M in Q1 2024, closing 12 positions and reducing 13 holdings. Its most notable exit was G-III Apparel Group, an estimated $25.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 26% a quarter earlier, followed by Communication Services and Technology.

Against the trend, Newtyn Management opened a new position in Cogent Communications worth $24.5M.

  • Newtyn Management's largest Q1 2024 buy was Cogent Communications: 375,000 shares worth $24.5M.
  • Newtyn Management added most to People Inc in Q1 2024, an estimated $11.2M increase.
  • Newtyn Management's biggest Q1 2024 reduction was Cannae Holdings, cutting an estimated $27.8M.
  • Newtyn Management fully exited G-III Apparel Group in Q1 2024, selling an estimated $25.8M.
  • Newtyn Management's ten largest holdings make up 69% of its $502M portfolio in Q1 2024.
  • Newtyn Management opened 4 new positions and closed 12 in Q1 2024.
  • Newtyn Management's portfolio value fell 1.4% quarter-over-quarter to $502M.

Based on Newtyn Management's 13F filing for Q1 2024, filed 15 May 2024.